The founders of Healx, Tim Guilliams and David Brown, had been advocating the use of AI for drug repurposing, and Nick became their inspiration. “Our mission is really simple,” says Guilliams. "We want 100 rare disease treatments ready for clinical use by 2025, at a much lower price and much faster pace.” The sweet spot of Healx is simple, Guilliams explains: “We use AI and Machine Learning to look at existing drugs to repurpose combinations for rare diseases." Click here to read more.